2021
Ischemic stroke is a leading cause of disability, with its treatment not yet optimal. It is thus mandatory to make (…)
Consulter
2021
In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received (…)
Consulter
2021
We classified non-demented European Prevention of Alzheimer’s Dementia (EPAD) participants through the amyloid/tau/neurodegeneration (ATN) scheme and assessed their neuropsychological and (…)
Consulter
2021
Consulter
2021
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic (…)
Consulter
2021
White matter hyperintensities (WMH) are often described in Alzheimer’s disease (AD), but their topography and specific relationships with cognition remain unclear.
Consulter